tirzepatide clinicaltrials gov Long-Term Safety of Tirzepatide: What Research and Experts Reveal In adults with obesity but

Eden is not affiliated with or endorsed by Eli Lilly and Company.

Results are from the Ideal Protein Protocol exclusively, without GLP-1 medication use

Vitamine B6

Sep 18 2021;13(9)doi:10.3390/nu13093256

Common upstream drivers in Hashimotos Gluten and cross-reactive foods in susceptible individuals Intestinal permeability (leaky gut) and mucosal barrier injury Dysbiosis (microbiome imbalance) and chronic GI inflammation Micronutrient deficits that impair antioxidant defense and immune regulation High stress physiology with poor sleep and autonomic dysregulation Infections that drive immune activation in genetically susceptible hosts Environmental toxins that increase inflammatory burden Gut health is central because a large portion of immune regulation occurs at the gut-immune interface

Several studies establish that both methods are safe and effective